不稳定型心绞痛患者内皮素及血管性假血友病因子的改变

目的 观察不稳定型心绞痛 (Unstableanginapectoris,UAP)患者内皮素 (Endothelin,ET)及血管性假血友病因子 (vonWillebrandfactor,vWF)的变化。方法 不稳定型心绞痛患者34例、正常人21名分别在清晨采血测定ET及vWF值。 结果 不稳定型心绞痛患者ET(129.3±26.4) pg/ml及vWF(185.4±32.4) %值明显高于正常人(85.2±39.6)pg/ml及(142.1±42.0) % ,两者之间不具有显著相关性 (r=0.15,P>0.05)。结论 ET及vWF的改变可能参与了不稳定型心绞痛的病理生理过程。     

Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.

AIMS: To evaluate the relationship between echocardiographic cardiac function and outcome in patients with stable symptomatic angina. METHODS: Baseline echo left ventricular ejection fraction and volume data measured in a central laboratory was available for 7016 patients (92% of the total) participating in the ACTION trial (A Coronary disease Trial Investigating Outcome with Nifedipine GITS). Ejection fraction was also measured by investigators. Evaluation of the different echocardiographic variables was based on adjusted hazard ratios comparing the unfavourable limit of the 90% range of the variable concerned to the favourable limit. RESULTS: The centrally measured ejection fraction was the most powerful predictor of all-cause death (adjusted hazard ratio=2.5), myocardial infarction, any stroke or transient ischaemic attack and overt heart failure (adjusted hazard ratio=4.5). The addition of either end systolic volume or end diastolic volume to ejection fraction did not materially affect the power of prediction. Compared to the central ejection fraction measurement, the investigator-measured ejection fraction was a less powerful predictor for all outcomes considered. CONCLUSION: Routine echocardiography carefully analysed by standardised methods provides useful prognostic information in patients with stable angina, including for total mortality.     

Vertebral body replacement system Synex in unstable burst fractures of the thoracic and lumbar spine

A prospective longitudinal study was performed to evaluate the vertebral body replacement system Synex associated with posterior fixation in unstable burst fractures of the lumbar and thoracic spine. Within 24 months, we treated 28 patients (average age, 41 years; range, 22–64 years; 14 women, 14 men) with acute unstable burst fractures without osteoporosis of the thoracolumbar region (n=16) and the thoracic (n=3) as well as the lumbar (n=9) spine in two stages (primary dorsal transpedicular stabilization and secondary vertebral body replacement). The complications were analyzed and the postoperative follow-up result was evaluated regarding stability, bone fusion, correction loss, pain and neurological status. One patient showed a transient irritation of the lumbosacral plexus and one patient had a superficial wound infection (complication rate, 7.1%). At the follow-up examination (mean follow-up, 13 months) only in two cases a minimal loss of correction (<5°) was measured. Radiologically, 27 patients showed secure bone fusions and all patients had stability of the osteosynthesis. Most of the patients stated no or just slight pain at follow-up. Only two patients with pain to a medium degree had to take painkillers. The vertebral body replacement system Synex seems to be a good alternative for vertebral body replacement in unstable burst fractures of the thoracic and lumbar spine since at present follow-up it shows a high rate of bone fusion and minimal loss of correction.     

Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease

BACKGROUND: Bone marrow cell injection has been introduced to treat patients with ischemic heart disease. However, focal application of bone marrow cells may generate an arrhythmogenic substrate. OBJECTIVES: To assess the electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia. METHODS: Bone marrow was aspirated in 20 patients (65+/-11 years, 19 male) with drug-refractory angina and myocardial ischemia. Electroanatomical mapping (NOGA, Biosense-Webster, Waterloo, Belgium) was performed during mononuclear cell isolation. Areas for cell injection were selected based on the localization of ischemia on SPECT. These areas were mapped in detail to evaluate local bipolar electrogram duration, amplitude and fragmentation. Mononuclear cells were injected in the ischemic area with the NOGA system. SPECT and electroanatomical mapping were repeated at 3 months. Holter monitoring was repeated at 3 and 6 months. RESULTS: SPECT revealed a decrease in the number of segments with ischemia (3.5+/-2.5 vs. 1.1+/-1.0 at 3 months; P<0.01) and an increased left ventricular ejection fraction (44+/-13% vs. 49+/-17% at 3 months; P=0.02). The number of ventricular premature beats remained unchanged (10+/-24x10(2)/24h vs. 8+/-23x10(2)/24h at 3 months (P=NS) and 12+/-30x10(2)/24h at 6 months (P=NS)). At 3 months follow-up, bone marrow cell injection did not prolong electrogram duration (15.9+/-4.6 ms vs. 15.6+/-4.0 ms; P=NS), decrease electrogram amplitude (3.8+/-1.5 mV vs. 3.8+/-1.5 mV; P=NS), or increase fragmentation (2.0+/-0.5 vs. 1.9+/-0.4; P=NS). CONCLUSION: Intramyocardial bone marrow cell injection does not increase the incidence of ventricular arrhythmias and does not alter the electrophysiological properties of the injected myocardium.     

心绞痛PTCA术后患者以步行为主的康复训练

１４例不稳定性心绞痛患者，男性１２例，女性２例，平均年龄５５岁，均因药物治疗无效而进行ＰＴＣＡ治疗。总计１６个血管段、前降支９段，回旋支４段，右冠状动脉３段。术后执行以步行为主要内容的一周康复训练程度，全部病例均顺利完成，表明以步为主的非监护康复训练对不稳定性心绞痛ＰＴＣＡ术后和是安全可行的。     

Emergency Treatment of Multiply Injured Patients with Unstable Disruption of the Posterior Pelvic Ring by Using the “C–Clamp”

Abstract Purpose: Evaluation of the therapeutic usefulness of the “pelvic C–clamp” (PCC) during emergency treatment of multiply injured patients with unstable disruption of the posterior pelvic ring. Patients and Methods: The data of 28 patients with polytrauma in combination with an unstable fracture of the posterior pelvic ring (average Injury Severity Score [ISS]: 49 points; average Polytrauma Score [PTS]: 41 points) were retrospectively analyzed from the moment they were admitted to the emergency room until 48 h after admittance. The PCC was used immediately for primary stabilization of the pelvis after clinical diagnosis of the unstable pelvic fracture. Main outcome measurements: development of mean blood pressure, development of oxygenation level, period of time until the PCC was placed, number of blood units needed, period of time until circulatory stabilization occurred. Results: The PCC was applied in all cases within an average of 64.7 min after trauma. Seven patients (25%) died within the first 45 min after admission. The surviving patients showed:• an increase in mean blood pressure of 25% 20 min after application of the PCC,• a hemodynamic stabilization 6 h after application of the PCC,• a stabilization of the oxygenation level 6 h after application of the PCC,• a decrease in the number of required blood units 6 h after application of the PCC. Conclusion: The present study shows, that the application of the PCC to critically injured patients with unstable pelvic fractures leads to stabilization of the vital parameters within a short period of time.     

不稳定性心绞痛患者肌钙蛋白I及C反应蛋白的临床意义

【目的】探讨不稳定性心绞痛 (UA)病变程度及其预后与血浆肌钙蛋白I (cTnI)及C反应蛋白(CRP)水平的关系。【方法】测定 5 8例经选择性冠状动脉造影证实为冠心病的患者血浆cTnI及CRP浓度 ,并与对照组 (健康者 5 0例 )相比较 ,分析cTnI及CRP的临床意义。【结果】①血浆cTnI及CRP浓度在对照组、稳定性心绞痛组 (SA)、UA组分别为 :(0 4 2± 0 0 6 ) μg/L ,(2 2 93± 10 8) μg/L ;(0 5 9± 0 13) μg/L ,(5 2 16± 32 8) μg/L ;(1 92± 0 5 8) μg/L ,(13811± 86 1) μg/L ;SA组及UA组明显高于对照组 (分别为P <0 0 5 ,P<0 0 1)。②观察 4w ,在UA组心脏事件发生率为 35 5 % ,明显高于SA组 (P <0 0 5 )。③cTnI与CRP具有一定相关性 (r =0 5 1,P <0 0 5 )。【结论】血浆cTnI及CRP水平在临床评价UA病情程度及预后方面具有一定的指导意义     

内皮素与P-选择素在冠心病中的意义

目的：研究内皮素（ET－1）、P－选择素、肌钙蛋白I（CTn1)在急性心肌梗死（AMI）和不稳定性心绞痛（UA）中的意义，方法：用放射免疫法测ET－1，流式细胞术测定P－选择素，Access化学发光测CTn1，共检测23例AMI患、21例UA患及28例健康对照。结果：AMI组的ET－1、P－选择素、CTn1值均显高于对照组（P＜0．05－0．005）；UA组的ET－1、P－选择素显高于对照组（P＜0．05）；UA组的CTn1与对照组差异无显性（P＞0．05）；UA组的P－选择素、CTn1显低于AMI组（P＜0．05）。多元回归分析发现P－选择与CTn1相关，相关系数r=0.404，P＜0．01。结论：ET－1、P－选择素是检测血栓前状态的敏感指标。     

通心络治疗冠心病心绞痛的临床观察

目的 :探讨通心络治疗心绞痛的临床疗效。方法 :选择 80例心绞痛患者随机分成治疗组和对照组 ,治疗组在内科常规治疗的基础上加用通心络口服 ,观察两组患者症状缓解情况以及停药后复发情况。结果 :治疗组的心绞痛疗效、复发率分别为 95 %和 16.7% ,对照组分别为 62 .5 %和 5 2 % ,有显著差异(P <0 .0 5 )。结论 :通心络在治疗心绞痛中疗效显著 ,复发率低 ,使用方便 ,是较理想的药物。     

祛瘀消斑胶囊治疗不稳定型心绞痛及对其血浆Fib、DD的影响

目的　观察祛瘀消斑胶囊治疗不稳定型心绞痛及对其血浆Fib和DD水平的影响。方法　对 4 0例不稳定型心绞痛患者随机分为常规西药加祛瘀消斑胶囊治疗组 (治疗组 )和常规西药治疗组 (对照组 ) ,治疗组与对照组各 2 0例。采用相应药物治疗 4周后 ,观察 2组患者的临床疗效、心电图改善及硝酸酯类药物的停减率 ,以及血浆Fib、DD水平变化 ,并进行比较分析。结果　治疗组可显著改善心绞痛症状 ,与对照组比较有显著性差异 (P <0 .0 5 ) ,2组患者心电图改善情况及硝酸酯类药物减停率无显著性差异 (P >0 .0 5 )。治疗组降低Fib、DD水平 ,与对照组比较有显著性差异 (P <0 .0 5 )。 2组均未出现明显不良反应。结论　祛瘀消斑胶囊可显著降低不稳定型心绞痛患者Fib、DD水平 ,联合西药治疗不稳定型心绞痛 ,疗效优于单用西药 ,且安全可靠。